ClinConnect ClinConnect Logo
Search / Trial NCT05397873

Biofeedback for Hemianopia Vision Rehabilitation

Launched by UNIVERSITY HEALTH NETWORK, TORONTO · May 24, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Hemianopsia Stroke Brain Tumor Brain Trauma Visual Fields Visual Loss Low Vision Fixation Stability Biofeedback Training Maia Microperimeter

ClinConnect Summary

This clinical trial is studying a new approach called biofeedback training (BT) to help people with hemianopia, which is a type of vision loss where a person can't see on one side of their visual field. This condition often occurs after a brain injury from a stroke, surgery, or trauma. The trial aims to see how effective biofeedback training can be in helping patients learn to move their eyes in a way that brings the areas they can't see into their line of sight. This training could potentially improve their ability to use their vision more effectively.

To be eligible for this trial, participants must be between 18 and 90 years old and have been diagnosed with hemianopia through tests like microperimetry. They should be able to follow simple visual and auditory instructions. However, individuals who have received prior treatment for low vision, have certain eye diseases, or other serious health issues unrelated to hemianopia won’t be included. Participants can expect to engage in training sessions that help them learn to adjust their eye movements, which might improve their daily activities and overall quality of life. The research team is currently recruiting participants, and the findings will help establish guidelines for using biofeedback training in vision rehabilitation for hemianopia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • hemianopia cases previously diagnosed accordingly by microperimetry and other tests as needed
  • 18-90 years old
  • ability to follow the visual and auditory stimuli and training instructions
  • Exclusion Criteria:
  • previous or current treatment for low vision rehabilitation
  • ocular diseases
  • other serious clinical conditions not related to the hemianopia physiopathology
  • both eyes with media opacity that impairs microperimetry testing
  • lack of ability to perform the tests and training

About University Health Network, Toronto

University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials